Correlation Between Helvetia Holding and Molecular Partners

Can any of the company-specific risk be diversified away by investing in both Helvetia Holding and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Helvetia Holding and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Helvetia Holding AG and Molecular Partners AG, you can compare the effects of market volatilities on Helvetia Holding and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Helvetia Holding with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Helvetia Holding and Molecular Partners.

Diversification Opportunities for Helvetia Holding and Molecular Partners

0.01

Correlation Coefficient

Helvetia Holding  Molecular Partners

Significant diversification

The 3 months correlation between Helvetia and Molecular is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Helvetia Holding AG and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Helvetia Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Helvetia Holding AG are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Helvetia Holding i.e., Helvetia Holding and Molecular Partners go up and down completely randomly.

Pair Corralation between Helvetia Holding and Molecular Partners

Assuming the 90 days trading horizon Helvetia Holding AG is expected to generate 0.23 times more return on investment than Molecular Partners. However, Helvetia Holding AG is 4.44 times less risky than Molecular Partners. It trades about 0.14 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.01 per unit of risk. If you would invest  15,220  in Helvetia Holding AG on October 22, 2024 and sell it today you would earn a total of  800.00  from holding Helvetia Holding AG or generate 5.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Helvetia Holding AG  vs.  Molecular Partners AG

Helvetia Holding

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Helvetia Holding AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Helvetia Holding may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Molecular Partners

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Helvetia Holding and Molecular Partners

The main advantage of trading using opposite Helvetia Holding and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Helvetia Holding position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.

The idea behind Helvetia Holding AG and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.